TETRAPHASE PHARMACEUTICALS I - COM (TTPH)

CUSIP: 88165N105

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
22,954,526
Share change
+1,249,436
Total reported value
$63,358,691
Put/Call ratio
528%
Price per share
$2.76
Number of holders
87
Value change
+$2,229,773
Number of buys
45
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 88165N105?
CUSIP 88165N105 identifies TTPH - TETRAPHASE PHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q3 2018

As of 30 Sep 2018, TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,954,526 shares. The largest 10 holders included BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, Vanguard Group Inc, STATE STREET CORP, NORTHERN TRUST CORP, Man Group plc, RENAISSANCE TECHNOLOGIES LLC, Tekla Capital Management LLC, 683 Capital Management, LLC, and JPMORGAN CHASE & CO. This page lists 87 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.